PNS246 EMA & G-BA - A COMPARISON OF TIME LIMITATIONS OF EUROPEAN MARKETING AUTHORIZATIONS AND GERMAN ADDED BENEFIT ASSESSMENTS FOR NEW PHARMACEUTICALS.
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI